ADVI Health

ADVI Health's team of leading #marketaccess and #biopharma experts understand and translate the impact of policy implementations for our clients and their product lifecycle. We form comprehensive and informed solutions based on our client's needs to ensure strategic guidance while working closely with #pharmaceutical and device manufacturers, and our collaborative and partner-based approach across all ADVI solutions is what allows us to ensure client success. Learn more about our market access and biopharma expertise: https://lnkd.in/eCh3_sQx #ADVISolutionSpotlight

ADVI Health recently conducted a survey of patients' experiences and specialty medication access with alternative funding programs (AFPs), which was published in the Journal of Managed Care & Specialty Pharmacy (JMCP). The survey consisted of 26 single- and multiple-choice questions to assess patients’ awareness of AFPs from their employers, experience with the patient assistance program application process via the AFP vendor, timeliness of medication access, and the health impact of delays. Responses were analyzed by disease and income level. A greater proportion of patients with hemophilia reported being anxious from waiting for their medication. Patients with lower income levels reported longer wait times. Read the full results of the study: https://lnkd.in/g3EyNaKt

Get to know Cynthia Campos, a senior researcher at ADVI Health. Bringing several years of expertise working on health outcomes studies for pharmaceutical and life sciences companies to the team, Cynthia works on a variety of projects at ADVI, including claims algorithms, systematic literature reviews, medical chart reviews, and expert Delphi panels. Learn more about Cynthia: https://lnkd.in/g4Dd-pY7 #ADVIExpertSpotlight

ADVI Health's head of federal and state policy, Lindsay Bealor Greenleaf, recently sat down with MedCity News to share insight on how a Trump administration will likely shake up the prescription drug world. In the article, "What Might the Future of Prescription Drugs Look Like Under Trump?," Lindsay discusses how she anticipates these changes will affect the #InflationReductionAct (IRA). Read the full article: https://lnkd.in/gUwCqgAn

Recently conducting a study on examining access to specialty medications through alternative funding programs (AFPs), ADVI Health Strategic Analytics, Value and Economics (SAVEs) senior director, Irina Yermilov, MD, MPH, MS, dives into these insights derived by her and her team - which was among one of the top four abstracts at this year's AMCP Nexus and received the Platinum Award. The study found that 61 percent of patients learned about AFPs as part of their health plan benefits while trying to obtain specialty medications rather than directly from their employer. 54 percent reported feeling uncomfortable with the AFP vendor representative, often feeling hesitant to share sensitive information. Learn more about this study: https://lnkd.in/e9ACBk2H

Last week, ADVI Health's head of federal and state policy, Lindsay Bealor Greenleaf, was featured in AJMC - The American Journal of Managed Care's article, "The Trump Sequel: What to Expect on PBMs, 340B, Drug Pricing, and RFK Jr." Lindsay shared her post-election insights on where she thinks these policies will stand during the lame duck period, and what she is watching for ahead of Trump's second administration. Read more of Lindsay's insights: https://lnkd.in/gDDuAzY8

This week at Journal of the Advanced Practitioner in Oncology (JADPRO) Live 2024 the abstract "Consensus guidance for management of nausea/vomiting in patients treated with zolbetuximab + chemotherapy: A RAND/UCLA modified Delphi panel study,” co-authored by ADVI Health’s Sarah Newman Gibbs, will be presented by Astellas Pharma medical director, Cassandra Matney MD, on November 17. Get in touch to learn more about our expertise and insights: https://lnkd.in/gU_DUshR #JADPROLive

At ADVI Health, as a leading #healthcare and #lifesciences strategic consulting partner, we solve complicated problems with data-informed commercialization, market access, and policy expertise. Our #ADVIExperts collaborate across ADVI's solution teams to offer the right mix of services and expertise for our clients, including federal and state policy, #marketaccess, reimbursement, and strategic analytics, value and economics (SAVEs). Learn more about our service offerings: https://lnkd.in/eZk2H2VH #ADVISolutionSpotlight

This week, ADVI Health CEO Marc Samuels is joining #lifesciences leaders and visionaries at the CNS Summit 2024 in Boston, MA. Marc will meet with clients and colleagues and looks forward to collaborative conversations, spotlight sessions, and presentations. Interested in meeting with Marc at #CNSSummit2024? Get in touch: https://lnkd.in/enw86f9k

How will the outcome of #Election2024 affect the course of US #healthcare? On November 14 at 12 pm ET, Managed Healthcare Executive will host a webinar, co-hosted by the Pharmacy Benefit Management Institute, where #ADVIExpert Lindsay Bealor Greenleaf will join Peter Wehrwein, Ryann Hill, and Patrick Cooney to discuss the future of the #AffordableCareAct (ACA), #InflationReductionAct (IRA), PBM reform, #Medicare, and #Medicaid. Learn more and register now: https://lnkd.in/gRDWDdeU